These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38011341)

  • 1. Association of cognitive impairment and quality of life in patients with multiple sclerosis: A cross-sectional study.
    Nabizadeh F; Balabandian M; Rostami MR; Owji M; Sahraian MA; Bidadian M; Ghadiri F; Rezaeimanesh N; Moghadasi AN
    Curr J Neurol; 2022 Jul; 21(3):144-150. PubMed ID: 38011341
    [No Abstract]   [Full Text] [Related]  

  • 2. The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorder.
    Rezaeimanesh N; Saeedi R; Sahraian MA; Ghadiri F; Naser Moghadasi A
    Curr J Neurol; 2022 Apr; 21(2):74-82. PubMed ID: 38011484
    [No Abstract]   [Full Text] [Related]  

  • 3. Demographic features, behavioral measures, and clinical factors as predictors of cognitive function in patients with multiple sclerosis.
    Alirezaei M; Forouzannia SM; Yarahmadi P; Sahraian MA; Owji M; Bidadian M; Ghadiri F; Naser Moghadasi A
    Mult Scler Relat Disord; 2021 Apr; 49():102758. PubMed ID: 33567391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients.
    Noori H; Gheini MR; Rezaeimanesh N; Saeedi R; Rezaei Aliabadi H; Sahraian MA; Naser Moghadasi A
    Mult Scler Relat Disord; 2019 Nov; 36():101415. PubMed ID: 31586799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
    Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
    Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis.
    Spiezia AL; Falco F; Manganelli A; Carotenuto A; Petracca M; Novarella F; Iacovazzo C; Servillo G; Lanzillo R; Brescia Morra V; Moccia M
    Mult Scler Relat Disord; 2023 Nov; 79():105044. PubMed ID: 37837668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcome measurements in a selective cohort of relapsing-remitting multiple sclerosis patients: relationships with physical disability, cognitive impairment, and MRI-derived metrics.
    London F; El Sankari S; De Haan A; Benyahia Z; Landenne G; Duprez T; van Pesch V
    Acta Neurol Belg; 2023 Jun; 123(3):1049-1059. PubMed ID: 36877357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-KEFS ST Failure Identifies Multiple Sclerosis Patients With Worse Objective and Self-Perceived Physical and Cognitive Disability.
    Riccardi A; Puthenparampil M; Rinaldi F; Ermani M; Perini P; Gallo P
    Front Psychol; 2019; 10():49. PubMed ID: 30733696
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin resistance is associated with cognitive dysfunction in multiple sclerosis patients: A cross-sectional study.
    Ayromlou H; Hosseini S; Khalili M; Ayromlou S; Khamudchiyan S; Farajdokht F; Hassannezhad S; Amiri Moghadam S
    J Neuroendocrinol; 2023 Jun; 35(6):e13288. PubMed ID: 37317829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and Reliability of Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Indonesia and the Correlation with Quality of Life.
    Estiasari R; Fajrina Y; Lastri DN; Melani S; Maharani K; Imran D; Pangeran D; Sitorus F
    Neurol Res Int; 2019; 2019():4290352. PubMed ID: 31263596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS).
    Skorve E; Lundervold AJ; Torkildsen Ø; Myhr KM
    Mult Scler Relat Disord; 2019 Nov; 36():101408. PubMed ID: 31610403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Maubeuge N; Deloire MSA; Brochet B; Ehrlé N; Charré-Morin J; Saubusse A; Ruet A;
    Mult Scler Relat Disord; 2021 Feb; 48():102692. PubMed ID: 33352358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined exercise training improves cognitive functions in multiple sclerosis patients with cognitive impairment: A single-blinded randomized controlled trial.
    Ozkul C; Guclu-Gunduz A; Eldemir K; Apaydin Y; Yazici G; Irkec C
    Mult Scler Relat Disord; 2020 Oct; 45():102419. PubMed ID: 32736216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that influence quality of life in patients with multiple sclerosis in Saudi Arabia.
    Abdulla FA; Albagmi FM; Al-Khamis FA
    Disabil Rehabil; 2022 Aug; 44(17):4775-4783. PubMed ID: 33966564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Fatigue with Depression, Disability Level and Quality of Life in Patients with Multiple Sclerosis.
    Kaya Aygünoğlu S; Çelebi A; Vardar N; Gürsoy E
    Noro Psikiyatr Ars; 2015 Sep; 52(3):247-251. PubMed ID: 28360718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
    Gromisch ES; Zemon V; Holtzer R; Chiaravalloti ND; DeLuca J; Beier M; Farrell E; Snyder S; Schairer LC; Glukhovsky L; Botvinick J; Sloan J; Picone MA; Kim S; Foley FW
    Clin Neuropsychol; 2016 Oct; 30(7):1032-49. PubMed ID: 27279357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of depression and anxiety on cognition in people with multiple sclerosis: a cross-sectional analysis.
    Freedman DE; Oh J; Kiss A; Puopolo J; Wishart M; Meza C; Feinstein A
    J Neurol; 2024 May; ():. PubMed ID: 38730098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.